China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) 5-Year Share Buyback Ratio : -0.20% (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is China Resourcesnjiu Medical & Pharmaceutical Co 5-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. China Resourcesnjiu Medical & Pharmaceutical Co's current 5-Year Share Buyback Ratio was -0.20%.

SZSE:000999's 5-Year Share Buyback Ratio is ranked better than
75.11% of 703 companies
in the Drug Manufacturers industry
Industry Median: -3 vs SZSE:000999: -0.20

Competitive Comparison of China Resourcesnjiu Medical & Pharmaceutical Co's 5-Year Share Buyback Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, China Resourcesnjiu Medical & Pharmaceutical Co's 5-Year Share Buyback Ratio, along with its competitors' market caps and 5-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Resourcesnjiu Medical & Pharmaceutical Co's 5-Year Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Resourcesnjiu Medical & Pharmaceutical Co's 5-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where China Resourcesnjiu Medical & Pharmaceutical Co's 5-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

China Resourcesnjiu Medical & Pharmaceutical Co 5-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from five years ago to the current year. The annualized percentage change is calculated with least-square regression based on the latest six years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) 5-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

China Resourcesnjiu Medical & Pharmaceutical Co 5-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of China Resourcesnjiu Medical & Pharmaceutical Co's 5-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resourcesnjiu Medical & Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Sanjiu Medical & Pharmaceutical Co Ltd (SZSE:000999) » Definitions » 5-Year Share Buyback Ratio

Traded in Other Exchanges

N/A

Address

High-Tech Park, Lake Street Mission Hills, Longhua District, Shenzhen, CHN, 518110

Website

http://www.999.com.cn

China Resources Sanjiu Medical & Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in the research and development, production and sale of pharmaceutical products, healthcare products, and medical appliances under the brand name 999, which includes OTC, antibiotic and raw material drug. The other brands under which the company offers its products are Lee King, Shunfeng, and Tianhe. The company's core business is located in OTC and Chinese medicine prescription drugs, OTC core products in the cold, gastrointestinal, skin, pediatric, cough and orthopedic drugs occupy a higher market share; prescription drug products in traditional Chinese medicine formula granules, cardiovascular and cerebrovascular, anti-tumor in the field of anti-infection and other areas.

Executives

Yang Zhan Ao	Executives
	Independent director
Li De Ming	Supervisors
Lin Xi Ping	Supervisors
Fang Ming	Director
Mai Yi	Executives

China Resourcesnjiu Medical & Pharmaceutical Co Headlines

No Headlines